Product Dossier
ACTRAPID
Product Dossier for ACTRAPID (insulin, Novo Nordisk Pharmaceuticals). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Novo Nordisk Pharmaceuticals
- Active ingredient: insulin
- Therapeutic area: Endocrinology
- Related brand: HUMULIN
- Same area: JANUMET
- Same area: LEVOXINE
I cannot write a
Brand Dossier for ACTRAPID based on the provided source documents.
The documents contain detailed product information for **Levemir** (insulin detemir), not ACTRAPID. While the second document confirms that ACTRAPID is a registered brand name for human insulin products sponsored by Novo Nordisk, it provides only minimal registration details (ARTG numbers and listing dates) and no clinical, safety, dosing, or regulatory information needed to populate a Brand Dossier.
To write an accurate Brand Dossier for ACTRAPID, I would need source documents containing: — Product information or approved labelling for ACTRAPID — Approved indications specific to ACTRAPID — Dosing information for ACTRAPID — Safety warnings and contraindications for ACTRAPID — PBS listing details for ACTRAPID strengths — Regulatory history including ARTG registration date and PBAC outcomes
The Levemir document, although comprehensive, cannot be used to support claims about ACTRAPID, as these are distinct insulin products with different formulations and properties.